We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUZ icon
376
Cousins Properties
CUZ
$5.22B
$88.9K ﹤0.01%
2,962
-213
-7% -$6.01K
KRG icon
377
Kite Realty
KRG
$5.91B
$87.8K ﹤0.01%
3,877
-284
-7% -$6.25K
RNAM
378
DELISTED
Avidity Biosciences
RNAM
$86.8K ﹤0.01%
3,055
– –
RARE icon
379
Ultragenyx Pharmaceutical
RARE
$2.56B
$86K ﹤0.01%
2,364
– –
SRRK icon
380
Scholar Rock
SRRK
$5.92B
$84.9K ﹤0.01%
2,396
– –
PTGX icon
381
Protagonist Therapeutics
PTGX
$8.8B
$84.3K ﹤0.01%
1,526
– –
COLD icon
382
Americold
COLD
$4.17B
$79.3K ﹤0.01%
4,771
-344
-7% -$6.24K
BRK.B icon
383
Berkshire Hathaway Class B
BRK.B
$1.11T
$78.7K ﹤0.01%
162
-1,385
-90% -$703K
EPR icon
384
EPR Properties
EPR
$4.92B
$78.2K ﹤0.01%
1,342
-92
-6% -$4.85K
PECO icon
385
Phillips Edison & Co
PECO
$5.48B
$77.6K ﹤0.01%
2,215
-107
-5% -$3.79K
SLG icon
386
SL Green Realty
SLG
$3.77B
$77.5K ﹤0.01%
1,252
-107
-8% -$6.13K
SBRA icon
387
Sabra Healthcare REIT
SBRA
$5.61B
$77.4K ﹤0.01%
4,196
-285
-6% -$5.06K
LEGN icon
388
Legend Biotech
LEGN
$3.68B
$74.2K ﹤0.01%
2,092
– –
KYMR icon
389
Kymera Therapeutics
KYMR
$8.73B
$72.4K ﹤0.01%
1,658
– –
MAC icon
390
Macerich
MAC
$7.52B
$72.1K ﹤0.01%
4,454
-253
-5% -$3.9K
IRT icon
391
Independence Realty Trust
IRT
$3.93B
$71.9K ﹤0.01%
4,065
-198
-5% -$3.72K
CRNX icon
392
Crinetics Pharmaceuticals
CRNX
$8.88B
$68.3K ﹤0.01%
2,375
– –
KRC icon
393
Kilroy Realty
KRC
$4.5B
$68K ﹤0.01%
1,982
-142
-7% -$4.63K
AMRX icon
394
Amneal Pharmaceuticals
AMRX
$5.99B
$64.2K ﹤0.01%
7,934
– –
MIRM icon
395
Mirum Pharmaceuticals
MIRM
$6.84B
$62.5K ﹤0.01%
1,228
– –
TIL icon
396
Instil Bio
TIL
$49.4M
$62.5K ﹤0.01%
+3,000
New +$62.7K
ALVO icon
397
Alvotech
ALVO
$1.05B
$62.3K ﹤0.01%
6,832
– –
MRP
398
Millrose Properties Inc
MRP
$4.75B
$62K ﹤0.01%
+2,176
New +$57.5K
SKT icon
399
Tanger
SKT
$4.84B
$61.2K ﹤0.01%
2,000
-97
-5% -$2.97K
XENE icon
400
Xenon Pharmaceuticals
XENE
$6.28B
$61.1K ﹤0.01%
1,952
– –
14 15
16
17 18

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.